title: Cerebrospinal fluid cytology diagnosis of HER2-positive leptomeningeal carcinomatosis from HER2-positive metastatic gastric cancer: case report.
authors.affiliation: Hospital of Piacenza, Piacenza, Italy.
authors.forename: Luigi
authors.initials: L
authors.lastname: Cavanna
authors.forename: Andrea
authors.initials: A
authors.lastname: Rocchi
authors.forename: Silvia
authors.initials: S
authors.lastname: Gorgni
authors.forename: Massimo
authors.initials: M
authors.lastname: Ambroggi
authors.forename: Raoul P
authors.initials: RP
authors.lastname: Foroni
authors.forename: Alessandro
authors.initials: A
authors.lastname: Ubbiali
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Civardi
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000556:secondary; D003581:Cytodiagnosis / Q000379:methods*; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D055756:Meningeal Carcinomatosis / Q000134:cerebrospinal fluid* / Q000188:drug therapy / Q000378:metabolism / Q000556:secondary*; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism; D013274:Stomach Neoplasms / Q000378:metabolism / Q000473:pathology*; D000068878:Trastuzumab
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018719:Erb-b2 Receptor Tyrosine Kinases; D000068878:Trastuzumab